Aspen Aerogels, Inc. Reports Second Quarter 2026 Financial Results and Recent
ASPEN AEROGELS INC (ASPN) filed an SEC Form 8-K — Results of Operations and Financial Condition. EXHIBIT 99.1 Aspen Aerogels, Inc. Reports Second Quarter 2026 Financial Results and Recent Business Highlights Q2 2026 Thermal Barrier revenue of $29.5 million, up 81% quarter-over-quarter Q3 2026 expected revenue range of $65 to $80 million and adjusted EBITDA range of $7 to $15
Facts are quoted from the filing text and checked against it.
How this was made
The 30-second read
Why it matters
Traders can reprice the stock based on the combination of a weak YoY Q2 revenue and net loss, plus a materially improved Q3 adjusted EBITDA range, while monitoring execution risk from the East Providence incident and the Statesboro asset sale process.
Market read
Fresh Q3 guidance ranges and incident cost assumptions create a clear near-term catalyst for earnings-model updates and risk management.
What to watch
Insurance recovery is expected to be collected in Q3, but guidance explicitly excludes business interruption recoveries, leaving margin outcomes sensitive to claim timing and incident-related cost creep.
Background
This SEC 8-K (Item 2.02) includes Aspen’s Q2 2026 financial results and a press-release exhibit with operational updates and forward guidance.
Ticker impact
Aspen reported Q2 2026 results and guided Q3 revenue $65M to $80M and adjusted EBITDA $7M to $15M, citing East Providence incident costs.
Near-term volatility likely around the Q3 outlook ranges and any market skepticism about insurance recovery timing and margin durability.
The filing provides fresh, decision-relevant numbers (Q2 print plus explicit Q3 revenue, net loss, and adjusted EBITDA ranges) and ties them to a specific operational disruption with insurance claims not assumed in the guidance.
Market effects
EV thermal barrier demand and regulatory/incentive sensitivity are highlighted as a driver of segment revenue volatility.
East Providence, Rhode Island manufacturing disruption and restart execution are central to near-term supply and cost dynamics.
European Thermal Barrier momentum and OEM program ramp (including JLR architectures) support longer-cycle demand visibility.
Counterpoint
The raised European outlook and JLR PyroThin award may not offset North American regulatory uncertainty quickly enough to sustain the adjusted EBITDA ramp.
Key entities
- issuerAspen Aerogels, Inc.
Reports Q2 2026 results, provides Q3 2026 guidance, and discusses the East Providence incident and staged manufacturing restart.
- customerJaguar Land Rover
Awarded Aspen’s PyroThin for two next-generation vehicle architectures with start of production expected in 2027.
- operational eventEast Providence incident (April 2026)
Property damage and incident-related costs drive Q2 losses; company expects insurance receivable collection in Q3.
